youtube_live
Kita sa Q3 2026 • Na-release • Nalampasan ang EPS +8.63% • Mas mataas ang kita +3.25%
Tingnan ang mga resultachevron_right
NOT:ETR
Novartis AG
€143.44
arrow_upward
+2.78%(+3.88) 1D
Okt 29, 4:53:06 PM GMT+1 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa NOT...
Buksan
€141.98
Mataas
€145.78
Mababa
€141.98
Mkt. cap
326.27B
Avg. na dami
5.16K
Dami
11.37K
Mataas nang 52-wk
€145.78
Mababa nang 52-wk
€104.52
Bilang ng mga empleyado
75K
Buksan
€141.98
Mataas
€145.78
Mababa
€141.98
Mkt. cap
326.27B
Avg. na dami
5.16K
Dami
11.37K
Mataas nang 52-wk
€145.78
Mababa nang 52-wk
€104.52
Bilang ng mga empleyado
75K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Fierce Pharma
·
4 oras ang nakalipas
Geron’s Rytelo stumbles in phase 3 as Novartis gears up for post-JAK inhibitor blood cancer bid
Seeking Alpha
·
4 oras ang nakalipas
Novartis AG 2026 Q3 - Results - Earnings Call Presentation (NYSE:NVS) 2026-10-29
Yahoo Finance
·
1 araw ang nakalipas
Lilly shuffles business structure; Novartis writes off part of Avidity deal
TradingView
·
1 araw ang nakalipas
What Novartis (NVS) Said on Its Q3 Earnings Call
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Tungkol sa Novartis AG
CEOVasant Narasimhan
Mga Empleyado75.3K
ItinatagMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
Sektor-
Websitenovartis.com